• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Blood-pressure-lowering effect of carvedilol vs nitrendipine in geriatric hypertensives.

作者信息

Krönig B, Widmann L, Staiger C, Machwirth M, Stienen U, Hennig M, Müller-Beckmann B

机构信息

Department of Internal Medicine, Elisabeth-Hospital, Trier, Federal Republic of Germany.

出版信息

Eur J Clin Pharmacol. 1990;38 Suppl 2:S167-70. doi: 10.1007/BF01409490.

DOI:10.1007/BF01409490
PMID:1974510
Abstract

Carvedilol and nitrendipine were given for 12 weeks in a double-blind study to 81 elderly patients (greater than or equal to 60 years) with essential hypertension. The effects on blood pressure were measured (Riva Rocci) before medication and after 2 h with the patient in a lying and standing position after 4 weeks of placebo therapy as well as after 4, 8 and 12 weeks of treatment. Carvedilol (25 mg/o.d.) reduced blood pressure measured in the supine and erect position very successfully, similar to the reduction achieved with nitrendipine (20 mg/o.d.), without influencing the pulse rate. Both substances were well tolerated. Carvedilol is an alternative substance for lowering high blood pressure in elderly hypertensive patients.

摘要

相似文献

1
Blood-pressure-lowering effect of carvedilol vs nitrendipine in geriatric hypertensives.
Eur J Clin Pharmacol. 1990;38 Suppl 2:S167-70. doi: 10.1007/BF01409490.
2
The use of carvedilol in elderly hypertensive patients.
Eur J Clin Pharmacol. 1990;38 Suppl 2:S129-33. doi: 10.1007/BF01409482.
3
Response rate with respect to the blood pressure-lowering effect of the vasodilating and beta-blocking agent carvedilol.关于血管舒张和β受体阻滞剂卡维地洛的降压效果的反应率。
Drugs. 1988;36 Suppl 6:92-101. doi: 10.2165/00003495-198800366-00016.
4
Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.与阿替洛尔相比,卡维地洛在接受氢氯噻嗪预处理的高血压患者中的疗效和安全性。
Eur J Clin Pharmacol. 1990;38 Suppl 2:S147-52. doi: 10.1007/BF01409486.
5
Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.卡维地洛与阿替洛尔单用及与氢氯噻嗪联用的安全性和降压疗效。
Eur J Clin Pharmacol. 1990;38 Suppl 2:S143-6. doi: 10.1007/BF01409485.
6
Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.每日一次卡维地洛与每日两次拉贝洛尔治疗轻至中度高血压的安全性和疗效比较。
Eur J Clin Pharmacol. 1990;38 Suppl 2:S164-6. doi: 10.1007/BF01409489.
7
Circadian antihypertensive profile of carvedilol (BM 14190).卡维地洛(BM 14190)的昼夜降压曲线
J Cardiovasc Pharmacol. 1987;10 Suppl 11:S119-23.
8
Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.双重α和β受体阻滞剂对原发性高血压的降压疗效。
Cochrane Database Syst Rev. 2015 Aug 26;2015(8):CD007449. doi: 10.1002/14651858.CD007449.pub2.
9
Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.卡维地洛对轻至中度高血压患者血压的影响。一项剂量反应研究。
Drugs. 1988;36 Suppl 6:82-91. doi: 10.2165/00003495-198800366-00015.
10
Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.新型血管扩张性β受体阻滞剂卡维地洛与阿替洛尔治疗轻至中度原发性高血压的比较。
Am J Hypertens. 1994 Feb;7(2):129-36. doi: 10.1093/ajh/7.2.129.

引用本文的文献

1
A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.卡维地洛与卡托普利对轻度至中度原发性高血压合并血脂异常患者血脂浓度影响的双盲比较。
Eur J Clin Pharmacol. 1993;45(2):95-100. doi: 10.1007/BF00315487.
2
Clinical pharmacokinetics and pharmacodynamics of carvedilol.卡维地洛的临床药代动力学与药效学
Clin Pharmacokinet. 1994 May;26(5):335-46. doi: 10.2165/00003088-199426050-00002.
3
Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

本文引用的文献

1
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels.老年人原发性高血压:血流动力学、血管内容量、血浆肾素活性及循环儿茶酚胺水平
Lancet. 1983 Oct 29;2(8357):983-6. doi: 10.1016/s0140-6736(83)90977-7.
2
Place of calcium antagonists in antihypertensive therapy: introduction and round-table discussion.
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S929-32.
3
Hypertension prevalence and the status of awareness, treatment, and control in the United States. Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee.美国高血压患病率及知晓、治疗与控制状况。1984年全国联合委员会定义与患病率小组委员会最终报告。
卡维地洛。对其药效学、药代动力学特性及治疗效果的综述。
Drugs. 1993 Feb;45(2):232-58. doi: 10.2165/00003495-199345020-00006.
4
Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.卡维地洛与普萘洛尔对冠心病患者急性血流动力学的影响比较。
Clin Investig. 1992;70 Suppl 1:S93-7. doi: 10.1007/BF00207618.
5
Antihypertensive profile of carvedilol.卡维地洛的降压概况。
Clin Investig. 1992;70 Suppl 1:S43-52. doi: 10.1007/BF00207611.
Hypertension. 1985 May-Jun;7(3 Pt 1):457-68. doi: 10.1161/01.hyp.7.3_pt_1.457.
4
Potential adverse effects of antihypertensive drugs in the elderly.抗高血压药物在老年人中的潜在不良反应。
J Hypertens Suppl. 1988 Nov;6(1):S81-5.
5
A new molecule with vasodilating and beta-adrenoceptor blocking properties.一种具有血管舒张和β-肾上腺素能受体阻断特性的新分子。
J Cardiovasc Pharmacol. 1987;10 Suppl 11:S23-32.
6
Evaluation of cardiovascular risk in the elderly: the Framingham study.老年人心血管风险评估:弗明汉姆研究
Bull N Y Acad Med. 1978 Jun;54(6):573-91.